- Revenues of
$54.6 million , an increase of 27% over Q1 2025, with growth across California Ethanol, Dairy RNG, and India Biodiesel segments - Gross profit of
$2.8 million , compared with a gross loss of$5.1 million in Q1 2025 - Operating loss improved approximately 60% to
$6.3 million , compared with$15.6 million in Q1 2025 - Aemetis Biogas RNG sales volume grew 55% to 110,000 MMBtu, compared with 71,000 MMBtu in Q1 2025
- India Biodiesel rebounded to
$10.5 million in revenue with the resumption of OMC tender shipments under new contracts $4.0 million of Section 45Z Production Tax Credits recognized in Q1 2026 — representing the first quarter of ongoing credits generation tied to quarterly production since 45Z eligibility was established in Q4 2025- Revenues include LCFS credits earned from seven Dairy RNG pathways with an average CI score of negative 380, versus the negative 150 default pathway that applied for Q1 2025 revenues — with 6 additional biogas pathways nearing approval
- First delivery of four dairy biogas pretreatment skids in April under
$27 million fabrication contract - First delivery of major equipment to
Keyes ethanol plant for$40 million Mechanical Vapor Recompression system - First delivery of major equipment for on-site RNG station to directly fuel trucks and gas delivery trailers without using utility gas pipeline
“Revenues during the first quarter of 2026 were
“We are pleased with the continued growth of Aemetis Biogas production, including the ramp up of volumes from a large centralized dairy digester to process waste from multiple dairies that became operational late last year,” said
Today,
Live Participant Dial In (Toll Free): +1-888-506-0062 entry code 943189
Live Participant Dial In (International): +1-973-528-0011 entry code 943189
Webcast URL: https://www.webcaster5.com/Webcast/Page/2211/53904
For details on the call, please visit http://www.aemetis.com/investors/conference-calls/
Financial Results for the Three Months Ended
Revenues were
Gross profit for the first quarter of 2026 was
Selling, general and administrative expenses decreased by
Operating loss was
Interest expense, excluding accretion of Series A preferred units in the
Net loss was
Adjusted EBITDA for the first quarter of 2026 was negative
Cash at the end of the first quarter of 2026 was
Section 45Z Production Tax Credits
During 2025,
Capital Structure and Financing Update
The Company is pursuing a multi-track financing plan to address near-term obligations and fund continued growth across its operating platform. Financing initiatives currently underway include advanced preparation for a potential long-term financing of the
About
Headquartered in
Non-GAAP Financial Information
We have provided non-GAAP measures as a supplement to financial results based on GAAP. A reconciliation of the non-GAAP measures to the most directly comparable GAAP measures is included in the accompanying supplemental data. Adjusted EBITDA is defined as net income/(loss) plus (to the extent deducted in calculating such net income) interest and amortization expense, bad debt expense, income tax expense or benefit, accretion of Series A preferred unit expense, stock issued for services, monetized investment tax credits, loss on sale of assets, depreciation and amortization expense, and share-based compensation expense.
Adjusted EBITDA is not calculated in accordance with GAAP and should not be considered as an alternative to net income/(loss), operating income or any other performance measures derived in accordance with GAAP or to cash flows from operating, investing or financing activities as an indicator of cash flows or as a measure of liquidity. Adjusted EBITDA is presented solely as a supplemental disclosure because management believes that it is a useful performance measure that is widely used within the industry in which we operate. In addition, management uses Adjusted EBITDA for reviewing financial results, budgeting, and planning purposes. EBITDA measures are not calculated in the same manner by all companies and, accordingly, may not be an appropriate measure for comparison between companies.
Safe Harbor Statement
This news release contains forward-looking statements, including statements regarding our assumptions, projections, expectations, targets, intentions, or beliefs about future events or other statements that are not historical facts. Forward-looking statements in this news release include, without limitation, statements relating to our five-year growth plan; trends in market conditions with respect to prices for inputs for our products versus prices for our products; our ability to fund, develop, build, maintain and operate digesters, facilities and pipelines for our
Company Investor Relations/
Media Contact:
(408) 213-0940
investors@aemetis.com
External Investor Relations Contact:
(646) 863-6519
ksmith@pcgadvisory.com
(Tables follow)
| CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS | |||||||||||
| (unaudited, in thousands, except per share data) | |||||||||||
| For the three months ended | |||||||||||
| 2026 | 2025 | ||||||||||
| Revenues | $ | 54,619 | $ | 42,886 | |||||||
| Cost of goods sold | 51,863 | 47,966 | |||||||||
| Gross profit (loss) | 2,756 | (5,080 | ) | ||||||||
| Selling, general and administrative expenses | 9,091 | 10,475 | |||||||||
| Operating loss | (6,335 | ) | (15,555 | ) | |||||||
| Other expense (income): | |||||||||||
| Interest expense | |||||||||||
| Interest rate expense | 12,403 | 11,018 | |||||||||
| Debt related fees and amortization expense | 1,971 | 2,675 | |||||||||
| Accretion and other expenses of Series A preferred units | 1,613 | 2,279 | |||||||||
| Total interest expense | 15,987 | 15,972 | |||||||||
| Other income | (478 | ) | (215 | ) | |||||||
| Other expense (income), net | 15,509 | 15,757 | |||||||||
| Loss before income taxes | (21,844 | ) | (31,312 | ) | |||||||
| Income tax benefit | (131 | ) | (6,783 | ) | |||||||
| Net loss | $ | (21,713 | ) | $ | (24,529 | ) | |||||
| Net loss per common share | |||||||||||
| Basic | $ | (0.33 | ) | $ | (0.47 | ) | |||||
| Diluted | $ | (0.33 | ) | $ | (0.47 | ) | |||||
| Weighted average shares outstanding | |||||||||||
| Basic | 66,802 | 52,584 | |||||||||
| Diluted | 66,802 | 52,584 | |||||||||
| CONSOLIDATED CONDENSED BALANCE SHEETS | ||||||||||||||
| (in thousands) | ||||||||||||||
| (Unaudited) | ||||||||||||||
| Assets | ||||||||||||||
| Current assets: | ||||||||||||||
| Cash and cash equivalents | $ | 4,797 | $ | 4,894 | ||||||||||
| Accounts receivable | 6,584 | 484 | ||||||||||||
| Inventories | 10,384 | 11,627 | ||||||||||||
| Prepaid and other current assets | 12,922 | 9,867 | ||||||||||||
| Total current assets | 34,687 | 26,872 | ||||||||||||
| Property, plant and equipment, net | 222,743 | 219,717 | ||||||||||||
| Other assets | 12,899 | 13,252 | ||||||||||||
| Total assets | $ | 270,329 | $ | 259,841 | ||||||||||
| Liabilities and stockholders' deficit | ||||||||||||||
| Current liabilities: | ||||||||||||||
| Accounts payable | $ | 23,719 | $ | 23,418 | ||||||||||
| Current portion of long term debt | 293,828 | 279,143 | ||||||||||||
| Short term borrowings | 48,802 | 38,726 | ||||||||||||
| Other current liabilities | 29,897 | 29,971 | ||||||||||||
| Total current liabilities | 396,246 | 371,258 | ||||||||||||
| Total long term liabilities | 195,221 | 195,414 | ||||||||||||
| Stockholders' deficit: | ||||||||||||||
| Common stock | 69 | 66 | ||||||||||||
| Additional paid-in capital | 348,741 | 340,402 | ||||||||||||
| Accumulated deficit | (661,656 | ) | (639,943 | ) | ||||||||||
| Accumulated other comprehensive loss | (8,292 | ) | (7,356 | ) | ||||||||||
| Total stockholders' deficit | (321,138 | ) | (306,831 | ) | ||||||||||
| Total liabilities and stockholders' deficit | $ | 270,329 | $ | 259,841 | ||||||||||
| RECONCILIATION OF ADJUSTED EBITDA TO NET INCOME/(LOSS) | |||||||||||
| (unaudited, in thousands) | |||||||||||
| For the three months ended | |||||||||||
| EBITDA Calculation | 2026 | 2025 | |||||||||
| Net loss | $ | (21,713 | ) | $ | (24,529 | ) | |||||
| Adjustments | |||||||||||
| Interest and amortization expense | 14,374 | 13,705 | |||||||||
| Depreciation and amortization expense | 2,535 | 2,357 | |||||||||
| Accretion of Series A preferred units | 1,613 | 2,279 | |||||||||
| Share-based compensation | 1,704 | 2,308 | |||||||||
| Stock issued for services | 50 | - | |||||||||
| Monetized investment tax credits | - | (7,075 | ) | ||||||||
| Bad debt Expense | 276 | - | |||||||||
| Loss on sale of assets | 2 | - | |||||||||
| Income tax expense or (benefit) | (131 | ) | 292 | ||||||||
| Total adjustments | 20,423 | 13,866 | |||||||||
| Adjusted EBITDA | $ | (1,290 | ) | $ | (10,663 | ) | |||||
| PRODUCTION AND PRICE PERFORMANCE | |||||||
| (unaudited) | |||||||
| Three Months ended | |||||||
| 2026 | 2025 | ||||||
| California Ethanol | |||||||
| Ethanol | |||||||
| Gallons sold (in millions) | 13.7 | 14.1 | |||||
| Average sales price/gallon | 1.97 | 1.98 | |||||
| Percent of nameplate capacity | 100 | % | 103 | % | |||
| WDG | |||||||
| Tons sold (in thousands) | 91 | 93 | |||||
| Average sales price/ton | $ | 84 | $ | 86 | |||
| Delivered Cost of Corn | |||||||
| Bushels ground (in millions) | 4.7 | 4.8 | |||||
| Average delivered cost / bushel | $ | 5.93 | $ | 6.63 | |||
| MMBtu sold (in thousands) | 110 | 71 | |||||
| Average price per MMBtu | $ | 1.98 | $ | 3.65 | |||
| RINs | |||||||
| RINs sold (in thousands) | 801 | 388 | |||||
| Average price per RIN | $ | 2.41 | $ | 2.64 | |||
| LCFS | |||||||
| LCFS credits sold (in thousands) | 30 | 16 | |||||
| Average price per LCFS credit | $ | 55.00 | $ | 72.50 | |||
| India Biodiesel | |||||||
| Biodiesel | |||||||
| Metric tons sold (in thousands) | 9.2 | - | |||||
| Average Sales Price/Metric ton | $ | 1,037 | $ | - | |||
| Percent of Nameplate Capacity | 24.5 | % | - | ||||
| Refined Glycerin | |||||||
| Metric tons sold (in thousands) | 0.8 | - | |||||
| Average Sales Price/Metric ton | $ | 1,257 | $ | - | |||
Source: 